MoneyWorks4Me

Sanofi India - Quaterly Results

14 May 2025 Evaluate
The total revenue for the quarter ended March 2025 remained nearly unchanged at Rs. 5359.00 millions.Handsome Net Profit growth of 65.97% reported above the corresponding previous quarter figure of Rs. 1195.00 millions to Rs. 720.00 millions.The company reported a good operating profit of 1752.00 millions compared to 1406.00 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202412 202312 % Var
Sales 5359.00 5108.00 4.91 5359.00 5108.00 4.91 20132.00 19961.00 0.86
Other Income 33.00 35.00 -5.71 33.00 35.00 -5.71 165.00 612.00 -73.04
PBIDT 1752.00 1406.00 24.61 1752.00 1406.00 24.61 5073.00 5489.00 -7.58
Interest 3.00 3.00 0.00 3.00 3.00 0.00 15.00 17.00 -11.76
PBDT 1749.00 1136.00 53.96 1749.00 1136.00 53.96 4681.00 5650.00 -17.15
Depreciation 96.00 91.00 5.49 96.00 91.00 5.49 367.00 365.00 0.55
PBT 1653.00 1045.00 58.18 1653.00 1045.00 58.18 4314.00 5285.00 -18.37
TAX 458.00 325.00 40.92 458.00 325.00 40.92 1177.00 1639.00 -28.19
Deferred Tax 1.00 -72.00 -101.39 1.00 -72.00 -101.39 -81.00 5.00 -1720.00
PAT 1195.00 720.00 65.97 1195.00 720.00 65.97 3137.00 3646.00 -13.96
Equity 230.00 230.00 0.00 230.00 230.00 0.00 230.00 230.00 0.00
PBIDTM(%) 32.69 27.53 18.77 32.69 27.53 18.77 25.20 27.50 -8.36
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..